A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors

NCT03486314 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Neoplasm

Interventions

DRUG: Pevonedistat
DRUG: Rifampin
DRUG: Docetaxel
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Millennium Pharmaceuticals, Inc.